Five insiders sell Replimune Group, Inc. shares, $1.89M in total
Five insiders reported sales totalling $1.89 million in Form 4 filings. By the Insider Stock Trader: Alerts app. Information only, not investment advice.
Form 4 filings show five Replimune Group, Inc. insiders selling stock between Nov 9 and Nov 16, for a total of $1.89 million.
Sushil Patel (CEO) made the largest sale, $1.06 million at an average of $21.60 a share. The table below lists who sold, when, and at what price.
Three or more insiders selling within 14 days is what Insider Stock Trader labels a cluster sell. Konstantinos Xynos (chief medical officer) is the latest to report, in a filing on Nov 18.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Joseph P Slattery | Director | Nov 9 | 5,200 | $21.80 | $113,360 | App · SEC |
| Emily Luisa Hill | CFO | Nov 16 | 14,709 | $21.60 | $317,714 | App · SEC |
| Sushil Patel | CEO | Nov 16 | 49,026 | $21.60 | $1,058,962 | App · SEC |
| Andrew Schwendenman | Chief Accounting Officer | Nov 16 | 2,148 | $21.60 | $46,397 | App · SEC |
| Konstantinos Xynos | Chief Medical Officer | Nov 16 | 16,198 | $21.60 | $349,877 | App · SEC |
| Total | $1,886,310 |
See the full REPL insider activity report
Each row of the table links to its Form 4 on SEC.gov.
Read more REPL insider trading news · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.